Business
Beyond “Patient Amusement”: New Treatments and Genetic Disease
Delete Delete, Jonah Broulette, Bruce S. Pyenson, FSA, MAAA, Kosuke Iwasaki, FIAJ, MAAA, Winghan Jacqueline Kwong, PharmD, PhD, Michael F. Murphy, MD, PhD
Warfarin Utilization in Medicare Patients with Nonvalvular Atrial Fibrillation: Sentinel Data from an Administrative Claims Database
Trends in Biologic Therapies for Rheumatoid Arthritis: Results from a Survey of Payers and Providers
Biologic Therapies for Rheumatoid Arthritis: It's All about Value
Louise A. Durst, RN, John Carlsen, MHA, Megan Kuchinski, MPH, Lauren Harner, JD, Daniel Neves, BA, Stephanie J. Harris, RN, BSN, Glenna L. Traiger, RN, MSN, CNS-BC
The Challenges of Pulmonary Arterial Hypertension Management: Potential Benefits of Removing Monthly Testing
Rahul Shenolikar, PhD, Amanda Schofield Bruno, PhD, MPH, Christopher Cantrell, PhD, Michael Eaddy, PharmD, PhD
We Need More Research on True Value-Based Benefit Design that Will Improve Outcomes and Control Costs
Medical Claims Data Can Inform Coverage Decisions in Managed Care Health Plans
We Must All Engage in the Diabetes Challenge: A Lifelong Journey, with No Silver Bullet
Health as a Sustainability Strategy: We Need a Healthcare System Focused on Keeping People Healthy Rather than Adding Layers to the Already Too Long, Fragmented Supply Chain